DFCI Pathology Core lab is looking forward to holding Akoya office hours on Tuesday, Sept 17th 9A-3P
Please stop by with your questions on how to set up an experiment or design a multiplex panel.
@KathleenHBurns@singh_namrata@FAbderazzaq#corelab@AkoyaBio
Last week, we featured the #PhenoCode Signature Immuno-Contexture panel and its use in profiling tumor immune infiltration. This week, we follow up with a complementary partner panel, the PhenoCode Signature T Cell Status Panel! 🌟 https://t.co/aQCpm7YUfR
This cutting-edge panel allows for the detailed identification of distinct T Cell subsets and effector functionality status within the #tumormicroenvironment, providing crucial insights for immunotherapy strategies. With the flexibility to add a sixth marker, you can tailor your analysis to meet specific research needs.
🧬 Key Features:
1️⃣ Targets key markers: CD8, CD4, CD20, FoxP3, PD-1
2️⃣ Customize further with an additional marker of your choice.
3️⃣ Supported by the #PhenoImager platform for precise and reproducible results.
Perfect for researchers aiming to push the boundaries of #cancerimmunotherapy and understand T-cell dynamics in depth. 🧫💡
Explore more about how the #TCell Status Panel can enhance your research: https://t.co/aQCpm7YUfR
Here, we feature PhenoCode Signature T Cell Status panel data from Namrata Singh and Kathleen Burns from the @DFCI_PathCore, looking to identify T cell subsets and assess their effector functionality within the TMEs, emphasizing the critical role of T-cells as drivers of anti-tumor immunity.
@DanaFarber #SpatialBiology #Immunotherapy #CancerResearch #Immunoflorescence #PhenoCodePanels #PhenoCodeSignature